Results 61 to 70 of about 3,305,589 (380)

Cause and timing of first allograft failure in orthotopic liver transplantation: A study of 177 consecutive patients [PDF]

open access: yes, 1991
The cause and timing of first liver allograft failure was evaluated in 177 patients who underwent a second liver transplant between January 1984 and December 1988.
Busuttil   +22 more
core   +1 more source

B-cell-mediated strategies to fight chronic allograft rejection

open access: yesFrontiers in Immunology, 2013
Solid organs have been transplanted for decades. Since the improvement in graft selection and in medical and surgical procedures, the likelihood of graft function after one year is now close to 90%.
Ali H Dalloul
doaj   +1 more source

Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25+ Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor

open access: yesFrontiers in Immunology, 2021
CD4+CD25+Foxp3+T cell population is heterogenous and contains three major sub-groups. First, thymus derived T regulatory cells (tTreg) that are naïve/resting. Second, activated/memory Treg that are produced by activation of tTreg by antigen and cytokines.
Bruce M. Hall   +17 more
doaj   +1 more source

The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation [PDF]

open access: yes, 1993
Previous findings in liver transplantation patients have raised the concept that HLA plays a dualistic role. HLA matching will reduce rejection but may augment MHC restricted cellular immune mechanisms of liver allograft injury. To evaluate this concept,
Demetris, AJ   +9 more
core   +1 more source

Graft‐Infiltrating Macrophages Adopt an M2 Phenotype and Are Inhibited by Purinergic Receptor P2X7 Antagonist in Chronic Rejection

open access: yesAmerican Journal of Transplantation, 2016
Macrophages exhibit diverse phenotypes and functions; they are also a major cell type infiltrating chronically rejected allografts. The exact phenotypes and roles of macrophages in chronic graft loss remain poorly defined. In the present study, we used a
Chenglin Wu   +9 more
semanticscholar   +1 more source

Differentiation of acute versus chronic skin rejection in a rodent model of vascularized composite allotransplantation

open access: yesFrontiers in Immunology
BackgroundVascularized composite allografts (VCA) have evolved to be a potential option in complex reconstructive surgery. However, managing acute and chronic allograft rejection remains challenging.
Julia Thomé   +11 more
doaj   +1 more source

Impact of Lung Function Decline on Mortality in Lung Transplant Recipients: Long-Term Results From the L-CsA-i Study for the Prevention of Bronchiolitis Obliterans Syndrome

open access: yesFrontiers in Medicine, 2022
BackgroundChronic lung allograft dysfunction (CLAD) is defined by a progressive loss of FEV1 and is associated with premature mortality. The aim of this study was to investigate the direct association between FEV1 decline and risk of mortality in ...
Nikolaus Kneidinger   +12 more
doaj   +1 more source

Baboon-to-human liver transplantation [PDF]

open access: yes, 1993
Our ability to control both the cellular and humoral components of xenograft rejection in laboratory experiments, together with an organ shortage that has placed limits on clinical transplantation services, prompted us to undertake a liver ...
A Tzakis   +43 more
core   +1 more source

Current status of xenotransplantation research and the strategies for preventing xenograft rejection

open access: yesFrontiers in Immunology, 2022
Transplantation is often the last resort for end-stage organ failures, e.g., kidney, liver, heart, lung, and pancreas. The shortage of donor organs is the main limiting factor for successful transplantation in humans.
Qiao Zhou   +11 more
doaj   +1 more source

Intestinal transplantation in composite visceral grafts or alone [PDF]

open access: yes, 1992
Under FK 506-based immunosuppression, the entire cadaver small bowel except for a few proximal and distal centimeters was translated to 17 randomly matched patients, of whom two had antigraft cytotoxic antibodies (positive cross-match).
Abu-Elmagd, K   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy